DHR vs. ABT

Last updated Apr 2, 2026

Compare and contrast key facts about Danaher Corporation (DHR) and Abbott Laboratories (ABT).

Performance

DHR vs. ABT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Danaher Corporation (DHR) and Abbott Laboratories (ABT). The values are adjusted to include any dividend payments, if applicable.

DHR vs. ABT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
DHR Danaher Corporation	-16.48%	0.35%	-0.35%	-1.22%	-19.02%	48.57%	45.34%	49.55%	11.80%	20.01%
ABT Abbott Laboratories	-17.87%	12.87%	4.81%	2.26%	-20.68%	30.53%	28.04%	22.08%	29.06%	52.03%

Fundamentals

Market Cap DHR : $135.65B ABT : $178.86B
EPS DHR : $5.06 ABT : $3.73
PE Ratio DHR : 37.73 ABT : 27.45
PS Ratio DHR : 5.55 ABT : 4.04
PB Ratio DHR : 2.58 ABT : 3.43
Total Revenue (TTM) DHR : $24.57B ABT : $44.33B
Gross Profit (TTM) DHR : $14.97B ABT : $24.61B
EBITDA (TTM) DHR : $7.02B ABT : $11.33B

Returns By Period

In the year-to-date period, DHR achieves a -16.48% return, which is significantly higher than ABT's -17.87% return. Over the past 10 years, DHR has outperformed ABT with an annualized return of 12.07%, while ABT has yielded a comparatively lower 11.33% annualized return.

DHR

• 1D: 0.63%
• 1M: -7.19%
• YTD: -16.48%
• 6M: -10.06%
• 1Y: -4.13%
• 3Y*: -4.61%
• 5Y*: -0.43%
• 10Y*: 12.07%

ABT

• 1D: -0.28%
• 1M: -10.29%
• YTD: -17.87%
• 6M: -22.56%
• 1Y: -20.80%
• 3Y*: 2.36%
• 5Y*: -1.16%
• 10Y*: 11.33%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

DHR vs. ABT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DHR

DHR Risk / Return Rank: 31
DHR Sharpe Ratio Rank: 34
DHR Sortino Ratio Rank: 30
DHR Omega Ratio Rank: 30
DHR Calmar Ratio Rank: 33
DHR Martin Ratio Rank: 28

ABT

ABT Risk / Return Rank: 7
ABT Sharpe Ratio Rank: 6
ABT Sortino Ratio Rank: 9
ABT Omega Ratio Rank: 8
ABT Calmar Ratio Rank: 10
ABT Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DHR vs. ABT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Danaher Corporation (DHR) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DHR	ABT	Difference
Sharpe ratio Return per unit of total volatility	-0.13	-0.90	+0.78
Sortino ratio Return per unit of downside risk	0.04	-1.10	+1.14
Omega ratio Gain probability vs. loss probability	1.01	0.84	+0.16
Calmar ratio Return relative to maximum drawdown	-0.25	-0.85	+0.60
Martin ratio Return relative to average drawdown	-0.75	-2.13	+1.38
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DHR vs. ABT - Sharpe Ratio Comparison

The current DHR Sharpe Ratio is -0.13, which is higher than the ABT Sharpe Ratio of -0.90. The chart below compares the historical Sharpe Ratios of DHR and ABT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	DHR	ABT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.13	-0.90	+0.78
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.02	-0.05	+0.04
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.48	0.48	0.00
Sharpe Ratio (All Time) Calculated using the full available price history	0.66	0.41	+0.25

Correlation

The correlation between DHR and ABT is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

DHR vs. ABT - Dividend Comparison

DHR's dividend yield for the trailing twelve months is around 0.71%, less than ABT's 2.34% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
DHR Danaher Corporation	0.71%	0.56%	0.47%	12.64%	0.38%	0.26%	0.32%	0.44%	0.62%	0.60%	32.55%	0.58%
ABT Abbott Laboratories	2.34%	1.88%	1.95%	1.85%	1.71%	1.28%	1.32%	1.47%	1.55%	1.86%	2.71%	2.14%

Drawdowns

DHR vs. ABT - Drawdown Comparison

The maximum DHR drawdown since its inception was -45.80%, smaller than the maximum ABT drawdown of -55.57%. Use the drawdown chart below to compare losses from any high point for DHR and ABT.

Drawdown Indicators

	DHR	ABT	Difference
Max Drawdown Largest peak-to-trough decline	-45.80%	-55.57%	+9.77%
Max Drawdown (1Y) Largest decline over 1 year	-24.85%	-25.18%	+0.33%
Max Drawdown (5Y) Largest decline over 5 years	-39.81%	-33.88%	-5.93%
Max Drawdown (10Y) Largest decline over 10 years	-39.81%	-33.88%	-5.93%
Current Drawdown Current decline from peak	-33.79%	-25.62%	-8.17%
Average Drawdown Average peak-to-trough decline	-10.09%	-14.29%	+4.20%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.44%	10.05%	-1.61%

Volatility

DHR vs. ABT - Volatility Comparison

Danaher Corporation (DHR) has a higher volatility of 8.96% compared to Abbott Laboratories (ABT) at 5.96%. This indicates that DHR's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DHR	ABT	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.96%	5.96%	+3.00%
Volatility (6M) Calculated over the trailing 6-month period	19.14%	16.81%	+2.33%
Volatility (1Y) Calculated over the trailing 1-year period	32.46%	23.10%	+9.36%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	27.75%	21.97%	+5.78%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.24%	23.57%	+1.67%

Financials

DHR vs. ABT - Profitability Comparison

The chart below illustrates the profitability comparison between Danaher Corporation and Abbott Laboratories over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

DHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported a gross profit of 3.97B and revenue of 6.84B. Therefore, the gross margin over that period was 58.0%.

ABT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported a gross profit of 6.54B and revenue of 11.46B. Therefore, the gross margin over that period was 57.1%.

DHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported an operating income of 1.50B and revenue of 6.84B, resulting in an operating margin of 22.0%.

ABT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported an operating income of 2.25B and revenue of 11.46B, resulting in an operating margin of 19.6%.

DHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported a net income of 1.20B and revenue of 6.84B, resulting in a net margin of 17.5%.

ABT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported a net income of 1.78B and revenue of 11.46B, resulting in a net margin of 15.5%.